​
​

IN8bio (INAB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

IN8bio Revenue Highlights

00

IN8bio Revenue by Period

IN8bio Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

IN8bio generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

IN8bio Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$3.75M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-06-30-100.00%
2018-03-31--

IN8bio generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

IN8bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
WVEWave Life Sciences$113.31M$19.69M
CUECue Biopharma$5.49M$3.34M
TFFPTFF Pharmaceuticals$733.87K$650.22K
LIFEaTyr Pharma$353.00K$235.00K
PALIPalisade Bio$250.00K-
ANIXAnixa Biosciences$210.00K-
GANXGain Therapeutics$55.18K-
GRCLGracell Bio--
RVPHReviva Pharmaceuticals--
CNSPCNS Pharmaceuticals--
ZURAZura Bio--
INABIN8bio--
ANNXAnnexon--
PYPDPolyPid--
CFRXContraFect--
LTRNLantern Pharma--
ALLRAllarity Therapeutics--
WINTWindtree Therapeutics--
INMBINmune Bio$-155.00K-

INAB Revenue FAQ

What is IN8bio’s yearly revenue?

IN8bio's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. INAB's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is IN8bio’s quarterly revenue?

IN8bio's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). INAB's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is IN8bio’s revenue growth rate?

IN8bio's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.